These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17330406)

  • 1. Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization.
    Kelland L
    Curr Opin Mol Ther; 2007 Feb; 9(1):86-91. PubMed ID: 17330406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherins as novel targets for anti-cancer therapy.
    Blaschuk OW; Devemy E
    Eur J Pharmacol; 2009 Dec; 625(1-3):195-8. PubMed ID: 19836380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.
    Yarom N; Stewart D; Avruch L; Malik R; Wells J; Jonker DJ
    Anticancer Res; 2011 Nov; 31(11):3921-5. PubMed ID: 22110220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
    Cao Y
    Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 6. ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer.
    Li H; Price DK; Figg WD
    Anticancer Drugs; 2007 Jun; 18(5):563-8. PubMed ID: 17414625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.
    Kuwada SK
    Curr Opin Mol Ther; 2007 Feb; 9(1):92-8. PubMed ID: 17330407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
    Cohen-Jonathan Moyal E
    Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma.
    Turley RS; Tokuhisa Y; Toshimitsu H; Lidsky ME; Padussis JC; Fontanella A; Deng W; Augustine CK; Beasley GM; Davies MA; Dewhirst MW; Tyler DS
    Ann Surg; 2015 Feb; 261(2):368-77. PubMed ID: 24646553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of angiogenesis: new hopes for oncologists, new challenges for anesthesiologists.
    Libert N; Tourtier JP; Védrine L; Chargari C
    Anesthesiology; 2010 Sep; 113(3):704-12. PubMed ID: 20693871
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin.
    Navaratna D; Maestas J; McGuire PG; Das A
    Arch Ophthalmol; 2008 Aug; 126(8):1082-8. PubMed ID: 18695103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer angiogenesis: targeting the heel of Achilles.
    Dass CR; Choong PF
    J Drug Target; 2008 Jul; 16(6):449-54. PubMed ID: 18604657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis in cancer].
    Pozner RG; Negrotto S; Schattner M
    Medicina (B Aires); 2002; 62(6):604-6. PubMed ID: 12532700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
    Mazeron R; Bourhis J; Deutsch E
    Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma.
    Mrozik KM; Cheong CM; Hewett D; Chow AW; Blaschuk OW; Zannettino AC; Vandyke K
    Br J Haematol; 2015 Nov; 171(3):387-99. PubMed ID: 26194766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FR-901228 Fujisawa/National Cancer Institute.
    Vigushin DM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1396-402. PubMed ID: 12498018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression.
    Shintani Y; Fukumoto Y; Chaika N; Grandgenett PM; Hollingsworth MA; Wheelock MJ; Johnson KR
    Int J Cancer; 2008 Jan; 122(1):71-7. PubMed ID: 17721921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
    Nicoli S; Ribatti D; Cotelli F; Presta M
    Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.